Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS

NAActive, not recruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Diarrhea-Predominant Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Postbiotic

1 capsule a day, 15 minutes before breakfast with a glass of water for 12 weeks

DIETARY_SUPPLEMENT

Placebo

1 capsule a day, 15 minutes before breakfast with a glass of water for 12 weeks

Trial Locations (23)

110059

Mata Roop Rani Maggo Hospital & IVF Center, New Delhi

221005

Samvedna Hospital, Varanasi

Ford Hospital, Uttar Pradesh

226012

Human care hospital, Uttar Pradesh

302039

Maharaja Agrasen Superspeciality Hospital, Jaipur

380006

HCG Hospital, Ahmedabad

380025

GCS Medical College, Hospital & Research Centre, Gujarat

390015

Nand Hospital, Gujarat

390016

Anand Multispeciality Hospital, Vadodara

400059

Stress Test Clinic, Mumbai

400069

Criticare Asia Multispeciality Hospital & Research Centre, Mumbai

400614

Apollo Hospital, Navi Mumbai

401303

Swara Hospital, Pālghar

411027

Gastrohub Hospital, Pune

411041

Birch Multispeciality Hospital, Maharashtra

411045

Umarji Mother and Child Care Hospital, Pune

412101

Lifeline Multispeciality Hospital, Pune

Lifeline multispeciality hospital, Maharashtra

421203

Asian Institute of Medical sciences, Thāne

422003

Surya Multispeciality Hospital, Nashik

422011

Astha Clinic, Nashik

Unknown

Maharaja Agrasen Superspeciality Hospital, Jaipur

Astha Clinic, Nashik

Sponsors
All Listed Sponsors
collaborator

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

lead

A-Mansia Biotech S.A.

INDUSTRY

NCT06346847 - Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS | Biotech Hunter | Biotech Hunter